s
UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics
29-08-2024, 14:32
SHENZHEN, China, Aug. 29, 2024 /PRNewswire/ — UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”), which continues to build on its strengths in the global healthcare sector, has announced that it has commenced a comprehensive financial and legal due diligence on Bowen Therapeutics Inc (“Bowen Therapeutics”), which it intends to acquire. The move marks an important […] L'articolo UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics proviene da La Ragione.
CONTINUA A LEGGERE
6
0
0
Guarda anche
La Ragione
20:43
Sinner ambassador di Milano-Cortina, Malagò “Ha entusiasmo e umiltà”
La Ragione
19:48